Literature DB >> 4076717

[Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine?].

J P Galmiche, J L Tranvouez, P Denis, C N'Djitoyap, J F Guillard, P A Lehur, R Colin.   

Abstract

The present work was conducted in patients with severe cimetidine-resistant duodenal ulcer, in order to correlate the response (i. e. healing or no healing of the ulcer) to ranitidine therapy and the results of 24 h gastric pH monitoring performed under therapeutic conditions. Twenty patients who fulfilled the criteria of cimetidine resistance (i. e. with an ulcer not healed after a treatment with cimetidine given at a dose of at least 1 g/d for at least 6 weeks) received 150 mg ranitidine twice daily for 6 weeks and were then controlled endoscopically; ulcer was healed in 8 cases, not healed in 12 cases. Nocturnal gastric acid inhibition was significantly greater in patients who responded to ranitidine than in those whose ulcer did not heal. During daytime the gastric pH profiles were not different between these two groups. Nocturnal pH score was also calculated in each patient by reference to the mean inhibitory effect observed in 8 normal subjects in whom gastric pH was monitored in the same therapeutic conditions. In 7 patients the nocturnal pH score was greater than 10; none of these patients was healed after 6 weeks ranitidine treatment. Among the 13 patients with a pH score lower than 10, 8 had an ulcer healed at the end of the ranitidine course. In 5 cases gastric pH monitoring was repeated after continuation of the ranitidine treatment; healing of ulcer was observed in 4 cases, always associated with a nocturnal pH score lower than 10 (in 2 cases after increasing the dosage of ranitidine).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4076717

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  4 in total

1.  Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.

Authors:  P Hemery; P Congard; J P Galmiche; S Bonfils
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Resistant duodenal ulcer: when, why and what to do?

Authors:  R P Walt; T K Daneshmend
Journal:  Postgrad Med J       Date:  1988-05       Impact factor: 2.401

3.  Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.

Authors:  J C Delchier; F Roudot-Thoraval; L Stanescu; M C Deharvengt; L Elouaer Blanc
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

4.  Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.

Authors:  J C Delchier; J P Isal; S Eriksson; J C Soule
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.